The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome

Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Since the introduction of plasma exchange as a treatment for Guillain-Barré syndrome (GBS) patients, treatment related fluctuations have been found to occur in about 10% of the patients. These fluctuations are considered additional evidence of the beneficial effect of plasma exchange. In this report the occurrence of such treatment related fluctuations is described in the 147 patients who took ...

Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome.

Characteristics of Guillain-Barré syndrome: brief report

Background: Guillain-Barré syndrome is an autoimmune inflammatory disease, which manifests itself as an acute motor weakness of the organs, diagnosed as affecting the motor spinal nerve roots generally and causing muscle and motor weakness, the cause of this disease is the presence of active antibodies against the myelin sheath around the spinal nerve roots. Guillain-Barré syndrome is the most ...

Detection of Autoantibodies against Gangliosides in Guillain-Barré Syndrome

Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome.

The use of intravenous infusions of immunoglobulin in the treatment of Guillain-Barre syndrome has become widespread. However, this treatment is not without morbidity. We describe an acute encephalopathy occurring in a patient receiving intravenous immunoglobulin infusions for Guillain-Barre syndrome. A 55 year old woman was admitted with a four week history of malaise and occasional rigors and...